Gold Entertainment Group Inc (GEGP): In my opinion GEGP doesn't have anything...

In my opinion GEGP doesn't have anything to

dolfan72 · 2014-07-15T12:29:36.7800000Z

In my opinion GEGP doesn't have anything to do with TTHX I believe it's a shell that belongs to Capitol Advisory International Inc. http://capitaladvisoryinternational.com/?page_id=2

Play Episode

6min

Proactive - Interviews for investors

Pluri CEO Yaky Yanay on pioneering cell-tech solutions for global needs

Pluri Inc. (NASDAQ:PLUR) CEO Yaky Yanay joined Proactive's Stephen Gunnion with more about the company’s progress in developing and commercializing its cell-based technology platform, highlighting recent partnerships, strategic financing, and future milestones. Pluri is a biotechnology company focused on manufacturing products derived from cells—including human, animal, and plant cells—for applications across industries such as healthcare, food, and agriculture. "We are taking this tiny organism, cells... and we create products out of them," Yanay explained. A key highlight was Pluri’s collaboration with Hemafund in Ukraine to enhance the country’s preparedness for radiation emergencies. Yanay detailed the use of PLX-R18, a placenta-based therapeutic developed with US federal agencies, which has shown potential to significantly improve survival rates following radiation exposure. The discussion also covered Pluri’s recent financing activities, including a $10 million raise and the acquisition of cacao company Kokomodo. These moves are part of Pluri’s broader expansion into the food sector, addressing shortages in coffee and cacao through cell cultivation in bioreactors. Looking ahead, Yanay emphasized a strong pipeline of deals for 2025, with a focus on sustainable, cell-based solutions for some of humanity’s biggest needs. For more interviews and updates, visit Proactive’s YouTube channel. Don’t forget to like this video, subscribe, and turn on notifications for future content. #PluriInc #BiotechInnovation #CellTherapy #SustainableTech #RadiationPreparedness #CoffeeCrisis #CacaoShortage #HealthcareTech #InvestmentNews #YakyYanay #ProactiveInvestors

Proactive - Interviews for investors

FDA approval sees Orthocell’s Remplir enter multi-billion dollar US nerve market

Orthocell Ltd chairman John van der Wielen talked with Proactive about the company receiving FDA clearance for its nerve repair product, Remplir, paving the way for entry into the multi-billion US healthcare market. The approval marks a significant milestone in Orthocell’s international growth strategy and reflects the strength of its regulatory and clinical capabilities. Van der Wielen emphasised the significance of breaking into the US market in a challenging regulatory environment. “Not many people would have thought with the current US turmoil, a company like ours could achieve FDA clearance,” he said. Orthocell has established operations in the US with logistics and distribution already in place. The company is implementing a hybrid sales model using in-house personnel and regional distributors, aiming for rapid initial uptake with an eye on more exclusive arrangements in the future. Remplir’s three-year shelf life and no temperature control requirement make it ideal for streamlined deployment. He also highlighted that Orthocell has already performed over 2,000 procedures in Australia and anticipates the US market to be 20 to 30 times larger, creating a strong revenue opportunity. With $32 million in cash reserves, the company expects to become cash flow positive within two years. 👉 For more interviews and updates, head to Proactive’s YouTube channel. Don’t forget to like the video, subscribe, and turn on notifications. #Orthocell #FDAApproval #Remplir #NerveRepair #MedicalDevices #BiotechNews #USHealthcare #OrthocellRemplir #InvestorUpdate #ProactiveInvestors #SurgicalInnovation #ASX

Proactive - Interviews for investors

Tonix Pharmaceuticals launches :TONIX ONE™ A digital breakthrough in migraine management

Tonix Pharmaceuticals is making waves in the healthcare industry with the launch of TONIX ONE™ a fully integrated digital platform designed to empower migraine patients with better tools for understanding and managing their condition. In an exclusive discussion with Proactive’s Steve Darling, Dr. Seth Lederman, CEO of Tonix Pharmaceuticals, unveiled the platform’s innovative features and strategic partnerships aimed at transforming migraine care. By collaborating with UpScript Telemedicine, ProModRx, Blink Health, and a leading mobile application specializing in disease tracking, symptom reporting, and management, TONIX ONE offers a comprehensive, patient-centric solution. Dr. Lederman highlighted that TONIX ONE™ beyond conventional migraine education by providing critical insights into the limitations of oral medications, which can sometimes result in delayed or ineffective symptom relief. The platform bridges the gap between patients and healthcare providers, offering direct access to migraine specialists via telehealth consultations and seamless e-prescription requests—ensuring a faster, more effective pathway to treatment. With this initiative, Tonix Pharmaceuticals aims to not only educate and empower patients in their treatment journey but also eliminate the barriers to care that many migraine sufferers face. By integrating advanced digital health solutions,TONIX ONE™ stands at the forefront of a new era in migraine management, offering patients greater control over their health and well-being. #proactiveinvestors #tonixpharmaceuticalsholdingcorp #nasdaq #tnxp #Biotech #MigraineTreatment #TonixOne #DigitalHealth #Telemedicine #ZembraceSymTouch #Tosymra #HealthcareInnovation #PharmaNews #ProactiveInvestors

Proactive - Interviews for investors

Standard Uranium forms alliance with Fleet Space Technologies for exploration at Davidson River

Standard Uranium Vice President of Exploration Sean Hillacre joined Steve Darling from Proactive to announce a major technological advancement in its exploration strategy through a newly formed strategic partnership with Fleet Space Technologies Canada Corp. This collaboration aims to enhance uranium discovery efforts on the company’s flagship Davidson River Project, located in the prolific southwestern Athabasca Basin—home to some of the world’s richest uranium deposits. Hillacre told Proactive the company will deploy Fleet Space’s cutting-edge Exosphere Multiphysics surveys represents a significant leap forward in exploration methodology. This advanced geophysical program combines real-time 3D Ambient Noise Tomography (ANT) and ground gravity surveys, providing powerful new data layers to improve geological targeting. The technology will be rolled out in spring 2025 across the Warrior, Bronco, and Thunderbird conductors—three of the most promising structural corridors on the Davidson River Project. By integrating ANT and gravity data, the surveys will generate 3D shear velocity models and custom density inversion models, which will serve as critical layers for drill targeting. These models are designed to pinpoint density anomalies in basement rocks, a key indicator of hydrothermal alteration processes often associated with uranium-bearing systems. This approach has been instrumental in the discovery of world-class uranium deposits elsewhere in the southwestern Athabasca Basin, and Standard Uranium aims to replicate that success with a data-driven targeting strategy. By adopting next-generation exploration tools, Standard Uranium continues to position itself at the forefront of innovative, high-impact uranium exploration. The company’s forward-thinking approach not only maximizes the scientific understanding of its projects but also creates substantial value for shareholders in a rapidly growing nuclear energy landscape. #proactiveinvestors #standarduraniumlt

Followers	4
Posts	209
Boards Moderated	0
Alias Born	04/01/2014

Volume:	4,000,000
Day Range:	0.0001 - 0.0001
Bid:	0.0001
Ask:	0.0001
Last Trade Time:	10:04:34 AM EDT
Total Trades:	3

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Discover

Boards:

Quotes:

GEGP Detailed Quote

Recent GEGP News

More GEGP News

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Discover

Boards:

Quotes:

Recent GEGP News

Go Ad-Free